Multimedia
Chairmen: Professor Derek Yellon & Professor Lionel Opie
Friday evening:
The Lancet Lecture: Stress and heart attacks.
Professor Sir Michael Marmot
Department of Epidemiology & Public Health, University College London, UK
Steps to control obesity, diabetes and hypertension: does industry have a role?
Dr. George Mensah
PepsiCo, New York, USA
Saturday morning:
Medical devices at the limits - a glimpse of the future.
Dr. William Wijns
Cardiovascular Centre Aalst, Belgium
The future of intervention for acute coronary syndromes - have we reached the limits?
Professor Keith Fox
University of Edinburgh, Scotland
The Pan African Society of Cardiology Lecture:
Hypertension control in Africa - an immense but not impossible task.
Professor Yackoob Seedat
University of KwaZulu Natal, South Africa
Prevention starts in the young – what are the practical limits?
Professor John Deanfield
University College London, UK
Saturday afternoon:
The South African Heart Association Lecture: Cholesterol medication in diabetics; does it lie in LDL lowering or HDL increase?
Professor Derick Raal
University of the Witwatersrand, South Africa
The hypertensive diabetic:- are we at the limits of therapy?
Professor Bryan Williams
University of Leicester, UK
Obese youth - is this synonymous with prediabetes and what are the limits?
Professor Sonia Caprio
Yale University, USA
The Hatter Lecture: The limits of anti-coagulation – will they ever be reached?
Professor Salim Yusuf
McMaster University and Hamilton Health Services, Ontario, Canada
Sunday morning:
Controversies in diabetes: getting to the heart of the problem
Professor Paul Zimmet
Baker IDI Heart and Diabetes Institute, Australia
Atrial Fibrillation – common and serious – but are we at the limits of prediction?
Professor Dirk van Veldhuisen
University Medical Center Groningen, The Netherlands
Ageing of the heart – surely there must be limits?
Professor Tim Noakes
University of Cape Town, South Africa
Monday morning debate:
Risk Management in diabetes: the role of incretins.
The case for GLP-1 analogues.
Professor Sten Madsbad, Hvidovre Hospital, Denmark
The case for DDP-4 inhibitors.
Professor Juris Meier, St. Josef-Hospital Bochum, Germany